Has Khalid Ismail, MD received payments from drug or device companies?

Yes. Drug and device makers reported $653 in general payments to Khalid Ismail, MD across 7 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Khalid Ismail, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Khalid Ismail, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Khalid Ismail, MD

Sleep Medicine · Boston, MANPI 1649287277

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 7 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Jazz Pharmaceuticals Inc. at 36.9% of the total. Reporting peaked in 2019 at $571 and has fallen 88.6% since, to $65 in 2025. That places this record below the midpoint for sleep medicine clinicians in MA, where the typical reported total is $559.

$653in general payments, 2019–2025

Across 7 payments — averaging $93.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Jazz Pharmaceuticals Inc.$241
Inspire Medical Systems, Inc.$174
ZOLL Respicardia, Inc.$127
Sentec, Inc.$65
Sanofi$29
Ardelyx, Inc.$17

What the payments were for

Food & beverage$653100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Jazz Pharmaceuticals Inc.	2	$241
Inspire Medical Systems, Inc.	1	$174
ZOLL Respicardia, Inc.	1	$127
Sentec, Inc.	1	$65
Sanofi	1	$29
Ardelyx, Inc.	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Inspire Upper Airway Stimulation System$174
XYREM$127
remede System$127

How this compares

$653 in reported general payments places this provider in the 50th percentile of 51 sleep medicine providers in Massachusetts.

See all sleep medicine providers in Massachusetts →

Medicare billing

Part B allowed, 2024

$119,201

Medicare patients

1,137

Services billed

2,066

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Advair HfaFluticasone Propion/Salmeterol	148	$82,696
Spiriva RespimatTiotropium Bromide	79	$51,625
SymbicortBudesonide/Formoterol Fumarate	60	$21,634
Trelegy ElliptaFluticasone/Umeclidin/Vilanter	27	$20,570
Incruse ElliptaUmeclidinium Bromide	37	$14,546
Breo ElliptaFluticasone/Vilanterol	30	$14,197
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate	56	$12,332
Stiolto RespimatTiotropium Br/Olodaterol Hcl	19	$9,665
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr	14	$7,954
Fluticasone-Salmeterol HfaFluticasone Propion/Salmeterol	17	$7,917
DuleraMometasone/Formoterol	15	$6,643
BreynaBudesonide/Formoterol Fumarate	12	$2,771
Fluticasone-SalmeterolFluticasone Propion/Salmeterol	16	$2,087
Wixela InhubFluticasone Propion/Salmeterol	11	$1,999
Albuterol Sulfate HfaAlbuterol Sulfate	48	$1,831

Paid to pharmacies, not to this prescriber.

Other sleep medicine in Boston

John WinkelmanBoston$104K
Suzanne BertischBoston$47K
Robert ThomasBoston$36K
Sogol JavaheriBoston$15K
Salma Batool AnwarBoston$5K
Daniel GottliebBoston$4K
Bethany BartleyBoston$4K
Stuart QuanBoston$3K
Phoebe YuBoston$3K
Umakanth KatwaBoston$3K

See the full list for Massachusetts →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →